Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 606-548-2 | CAS number: 204254-84-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-02-10 to 1998-02-24
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in compliance with minor deviations from current standard test guidelines and/or minor methodological deficiencies. However, these deviations do not adversely affect the overall conclusions or the quality of the relevant results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- yes
- Remarks:
- minor deviations such as age of rats at dosing
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- yes
- Remarks:
- minor
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
Test material
- Reference substance name:
- Ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate
- EC Number:
- 606-548-2
- Cas Number:
- 204254-84-2
- Molecular formula:
- C13 H20 O7 S
- IUPAC Name:
- Ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Purity 98.5%
Retest date: 17 October 1998
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Rats were ~6 weeks old at dosing. Body weight range at start of dosing M: 126.5-144.1 g, F: 102.1-115.3 g. Group size = 5 rats/sex, housed singly. Temperature 22°C ± 2°C, Relative humidity 50% +/- 10%. Lighting Fluorescent tubes, 12 hours light/dark cycle.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 5g Sodium Carboxymethylcellulose, 4 mL Tween 80, 5 mL Benzylalcohol and NaCl (0.9%) to 1 L
- Details on oral exposure:
- Animals were fasted overnight and access to feed was given 3 hours after dosing. Dose administered at 15 mL/kg
- Doses:
- The dose was selected on the basis of a preliminary toxicity study with 3 rats. The animals received a single oral administration of 500 or 2000 mg/kg. All doses were well tolerated. For the main study the dose level of 2000 mg/kg was selected.
- No. of animals per sex per dose:
- 5 males and 5 females per dose level
- Control animals:
- not specified
- Details on study design:
- Clinical Observations and examinations:
Mortalities: Daily
Clinical symptoms: Daily
Body weight development: 2-3 times/week
Results and discussion
- Preliminary study:
- The animals (sex not stated) received a single oral administration of 500 or 2000 mg/kg. All doses were well tolerated.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- other: Maximum Tolerated Dose
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Single-dose administration of 2000 mg/kg (by gavage) was well tolerated in the rats.
No mortalities occurred during the 14-day observation period - Clinical signs:
- other: Single-dose administration of 2000 mg/kg (by gavage) was well tolerated in the rats. No uncommon clinical signs were observed during the 14-day observation period
- Gross pathology:
- At necropsy, no macroscopic findings were observed in any of the rats.
- Other findings:
- No histopathological evaluation of organs or tissues was included in this study because no uncommon clinical signs were noted during the 14-day observation period and no macroscopic findings were observed at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The maximum tolerated dose (MTD) in the rat after acute oral administration was more than 2000 mg/kg bw.
- Executive summary:
A single-dose administration of 2000 mg/kg body weight of the test item (by gavage) was well tolerated in male and female rats. No mortalities occurred and no uncommon clinical signs were observed during the 14-day observation period. Furthermore, no macroscopic findings were noted at necropsy.
The maximum tolerated dose (MTD) in the rat after acute oral administration was more than 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
